4.5 Article

Multinational and multiethnic variations in health-related quality of life in patients with chronic heart failure

Journal

AMERICAN HEART JOURNAL
Volume 191, Issue -, Pages 75-81

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.ahj.2017.06.016

Keywords

-

Funding

  1. NHLBI NIH HHS [U10 HL110312] Funding Source: Medline
  2. NIA NIH HHS [R01 AG045551] Funding Source: Medline

Ask authors/readers for more resources

Background Assessing health-related quality of life (HRQoL) in patients with heart failure (HF) is an important goal of clinical care and HF research. We sought to investigate ethnic differences in perceived HRQoL and its association with mortality among patients with HF and left ventricular ejection fraction <= 35%, controlling for demographic characteristics and HF severity. Methods and results We compared 5697 chronic HF patients of Indian (26%), white (23%), Chinese (17%), Japanese/Koreans (12%), black (12%), andMalay (10%) ethnicities from the HF-ACTION and ASIAN-HF multinational studies using the Kansas City Cardiomyopathy Questionnaire (KCCQ; range 0-100; higher scores reflect better health status). KCCQ scores were lowest in Malay (58 +/- 22) and Chinese (60 +/- 23), intermediate in black (64 +/- 21) and Indian (65 +/- 23), and highest in white (67 +/- 20) and Japanese or Korean patients (67 +/- 22) after adjusting for age, sex, educational status, HF severity, and risk factors. Self-efficacy, which measures confidence in the ability to manage symptoms, was lower in all Asian ethnicities (especially Japanese/Koreans [60 +/- 26], Malay [66 +/- 23], and Chinese [64 +/- 28]) compared to black (80 +/- 21) and white (82 +/- 19) patients, even after multivariable adjustment (P < .001). In all ethnicities, KCCQ strongly predicted 1-year mortality (HR 0.45, 95% CI 0.30-0.67 for highest vs lowest quintile of KCCQ; P for interaction by ethnicity.101). Conclusions Overall, HRQoL is inversely and independently related to mortality in chronic HF but is not modified by ethnicity. Nevertheless, ethnic differences exist independent of HF severity and comorbidities. These data may have important implications for future global clinical HF trials that use patient-reported outcomes as endpoints.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available